Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes.Liver Transpl. 2015; 21: 487-499
- Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.Am J Transplant. 2021; 21: 614-625
- The Role of ischemia/reperfusion injury in early hepatic allograft dysfunction.Liver Transpl. 2020; 26: 1034-1048
- Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.Liver Transpl. 2010; 16: 943-949
- Primary nonfunction of the liver allograft.Transplantation. 2022; 106: 117-128
- Etiology and management of hepatic artery thrombosis after adult liver transplantation.Liver Transpl. 2014; 20: 713-723
- Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients.J Am Coll Surg. 2009; 208 ([discussion: 903–5]): 896-903
- Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors.Am J Transplant. 2009; 9: 746-757
- Small-for-size syndrome in liver transplantation: new horizons to cover with a good launchpad.Liver Transpl. 2016; 22: 33-36
- Small-for-size syndrome in LT.Clin Liver Dis. 2017; 10: 93-96
- Biliary complications after liver transplantation.Clin Transplant. 2006; 20: 93-96
- Biliary complications after liver transplantation: old problems and new challenges.Am J Transplant. 2013; 13: 253-265
- Early Biliary complications after liver transplantation.Clin Liver Dis. 2017; 10: 63-67
- Long-term follow-up of endoscopic therapy for stenosis of the biliobiliary anastomosis associated with orthotopic liver transplantation.Liver Transpl. 2013; 19: 586-593
- Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.Transpl Int. 2010; 23: 611-618
- Biliary complications and outcomes of liver transplantation from donors after cardiac death.Liver Transpl. 2007; 13: 1645-1653
- Diagnostic value of ultrasound in detection of biliary tract complications after liver transplantation.Hepat Mon. 2013; 13: e6003
- International liver transplantation Society consensus Statement on immunosuppression in liver transplant recipients.Transplantation. 2018; 102: 727-743
- 2016 Comprehensive Update of the Banff working Group on liver allograft pathology: Introduction of antibody-mediated rejection.Am J Transplant. 2016; 16: 2816-2835
- Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology.Transplantation. 1995; 59: 740-746
- Biochemical and histopathological correlation in liver transplant: the first 180 days.Hepatology. 1992; 16: 688-693
- Banff schema for grading liver allograft rejection: an international consensus document.Hepatology. 1997; 25: 658-663
- Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.Hepatology. 2000; 31: 792-799
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.Gastroenterology. 1999; 117: 619-625
- The natural history of recurrent hepatitis C and what influences this.Liver Transpl. 2008; 14: S36-S44
- Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.Hepatology. 1991; 13: 619-626
- Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.J Viral Hepat. 2017; 24: 789-796
- A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation.Liver Int. 2011; 31: 1477-1484
- Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.Gastroenterology. 2011; 141: 1212-1219
- Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.J Hepatol. 2020; 73: 559-565
- Factors associated with recurrence of primary biliary cholangitis after liver transplantation and Effects on graft and patient survival.Gastroenterology. 2019; 156: 96-107.e1
- Recurrent primary biliary cirrhosis.Liver Transpl. 2003; 9: 539-546
- Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.Liver Transpl. 2007; 13: 1236-1245
- Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.J Hepatol. 2015; 63: 1139-1146
- Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis.Liver Transpl. 2016; 22: 42-52
- Recurrence of primary sclerosing cholangitis following liver transplantation.Hepatology. 1999; 29: 1050-1056
- Liver transplantation and autoimmune liver diseases.Liver Transpl. 2013; 19: 1065-1077
- Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.Aliment Pharmacol Ther. 2019; 49: 636-643
- Recurrent and de novo autoimmune hepatitis.Liver Transpl. 2019; 25: 152-166
- Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.J Hepatol. 2022; https://doi.org/10.1016/j.jhep.2022.01.022
- Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.J Hepatol. 1999; 30: 131-141
- Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient.Liver Transpl. 2001; 7: 556-558
- Risk factors for recurrence of autoimmune hepatitis after liver transplantation.Liver Transpl. 2009; 15: 1254-1261
- Incidence and risks for Nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis.Transplantation. 2019; 103: e345-e354
- NAFLD and liver transplantation: current burden and expected challenges.J Hepatol. 2016; 65: 1245-1257
- Metabolic complications in liver transplant recipients: How we can Optimize long-term survival.Liver Transpl. 2021; https://doi.org/10.1002/lt.26219
- PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.Public Health Rep. 2013; 128: 247-343
- Infection in organ transplantation.Am J Transplant. 2017; 17: 856-879
- Unexpected hepatitis B virus infection after liver transplantation - United States, 2014-2019.MMWR Morb Mortal Wkly Rep. 2021; 70: 961-966
- Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus-negative recipients: a Real-World experience.Hepatology. 2020; 72: 32-41
- Prospective multicenter study of early antiviral therapy in liver and kidney transplant recipients of HCV-viremic donors.Hepatology. 2021; 73: 2110-2123
- Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.Am J Transplant. 2019; 19: 1380-1387
- Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.Am J Transplant. 2020; 20: 1619-1628
- Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era.Am J Transplant. 2020; 20: 600-605
- Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.Am J Transplant. 2015; 15: 1162-1172
- Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.Clin Transplant. 2011; 25: E243-E249
- Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.Gastroenterology. 2011; 140: 1481-1489
- Hepatitis E virus and chronic hepatitis in organ-transplant recipients.N Engl J Med. 2008; 358: 811-817
- Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of transplantation infectious diseases community of Practice.Clin Transplant. 2019; 33: e13512
- Lymphomas after solid organ transplantation: a collaborative transplant study report.Am J Transplant. 2004; 4: 222-230
- Abnormal liver function tests in patients with COVID-19: Relevance and potential Pathogenesis.Hepatology. 2020; 72: 1864-1872
- Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.Lancet Gastroenterol Hepatol. 2020; 5: 1008-1016
- COVID-19 and liver disease: mechanistic and clinical perspectives.Nat Rev Gastroenterol Hepatol. 2021; 18: 348-364
- Outpatient management of liver function test Abnormalities in patients with a liver transplant.JAMA. 2020; 324: 1896-1897
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
